Clariant and India Glycols Limited created a JV for renewable ethylene oxide derivatives

Clariant Image CIC MainEntrance 2 S
Source: Clariant

Clariant, a focused, sustainable and innovative specialty chemical company, and India Glycols Limited (IGL), a leading company in the manufacturing of green technology-based chemicals, successfully created their 51-49% joint venture for renewable ethylene oxide (EO) derivatives after receiving all necessary regulatory approvals. The joint venture will operate under the name Clariant IGL Specialty Chemicals Private Limited.

Continue reading

Global Bioenergies is going to launch its LAST longwear cosmetic brand

8A535D57-8A63-4471-A3C5-2C8CE1768448
Source: Global Bioenergies

French biotech company Global Bioenergies announced the upcoming launch of its “LAST®” longwear cosmetics brand in June 2021. Eighteen products will comprise the world’s first range of longwear, transfer-resistant and waterproof eye make-up to use natural ingredients. This groundbreaking performance is based on the renewable isododecane produced by the Company as the main ingredient of its formulations. Products have been designed with over 90% natural ingredients and packaging to minimise their environmental footprint.

Continue reading

DMC Biotech and Conagen joined forces for the commercial production of L-alanine

B0528988-5CF5-4EAD-93C7-7D30298AC096

Denver, Colorado

DMC Biotechnologies and Conagen Inc. have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine. L-alanine is a naturally occurring amino acid used widely in homecare products, human nutrition, and pharmaceutical applications. DMC’s fermentation technology enables L-alanine to be produced with attractive economics as part of a regional supply chain with increased reliability and greater sustainability.

Continue reading

An exclusive interview with Nicolas Sordet, founder and CEO Afyren

4BD43DA4-F7BA-4EB9-8D48-DC12859FB049

“Simplification of the European regulatory framework could also go a long way toward accelerating and promoting the circular bioeconomy surge.“ Nicolas Sordet, founder and CEO of AFYREN, talks to Il Bioeconomista. Founded in 2012 and headquartered in France, AFYREN collected more than €70 million funding in 2019, which allows the company to grow from a pilot stage to industrial-scale production.

Interview by Mario Bonaccorso

Continue reading

Circa Group successfully completed €56 million IPO on Euronext Growth Oslo

Tony Duncan, CEO of Circa Group, at IFIB 2018 in Turin

Australian biochemicals company Circa Group AS has successfully completed a private placement of 575 Norwegian Kroner (NOK) – approximately €56 million – in a transaction led by Pareto Securities and Sparebank 1 Markets in Oslo, at a post-money market valuation of approximately NOK 2 billion (approximately €194 million). The company (ticker code: CIRCA) shares started trading on Euronext Growth Oslo at 09:00 CET yesterday (2 March 2021).

Continue reading

An interview with Jason Camp, CTO at Circa Group

“It is in everyone’s interests for life-sustaining chemicals to be manufactured both safely and reliably. We would argue that it is also extremely important that those chemicals be as sustainable as possible, so that future generations will have a habitable plant to use them on.” Jason Camp, CTO at Circa Group, talks to Il Bioeconomista. The Australia-based company is converting waste biomass into advanced biochemical materials.

Interview by Mario Bonaccorso

Continue reading

An interview with Matt Lipscomb, CEO DMC Bio

Matt Lipscomb

“We are hoping that the next US government will take climate change seriously and will take material steps to improve its leadership on the global stage.”

To say it – in this exclusive interview with Il Bioeconomista – is Matt Lipscomb, CEO of DMC Bio, the US company which is producing bio-based chemicals using fermentation.

Interview by Mario Bonaccorso

Continue reading

Amyris and IDRI signed a binding term sheet for a planned Covid-19 RNA vaccine technology

John Melo, President and Ceo of Amyris

Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets and IDRI (Infectious Disease Research Institute) signed a binding term sheet for a planned COVID-19 RNA (ribonucleic acid) vaccine technology program. The program combines IDRI’s expertise in combating infectious diseases with Amyris’ fermentation platform technology, with the goal to create semi-synthetic squalene-based adjuvants at scale.

Continue reading

Manufacturers of biomass-derived chemicals created a new sector group within the Cefic

Daniele Ferrari, President of Cefic. Courtesy of Versalis

In response to the growing importance of bio-based renewable raw materials, manufacturers of biomass-derived chemicals created a new sector group within the European Chemical Industry Council (Cefic): Biomass-derived Chemicals Europe (BioChem Europe). The group represents companies using feedstocks based on biomass as their raw materials to produce chemicals.

Continue reading

Sekab and Vertoro to build large-scale demo plant to produce a new platform for sustainable fuels, chemicals, and materials

A new demo plant in Örnsköldsvik will be the first in the world to produce a 2G platform for sustainable fuels, chemicals and materials, coined GOLDILOCKS®, from pulp and paper industry residues. The plant will be built by the Swedish chemical and clean tech company Sekab together with the Dutch oil company Vertoro.

Continue reading